Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 74Prostatic Neoplasms 54Breast Neoplasms 15Neoplasms 11Sarcoma 10Endometrial Neoplasms 10Vaginal Neoplasms 8Esophageal Neoplasms 6Uterine Neoplasms 5Radiation Injuries 5Lung Neoplasms 5Liver Neoplasms 5Vulvar Neoplasms 4Glioblastoma 4Carcinoma, Ductal, Breast 4Adenocarcinoma 4Retinoblastoma 3Ovarian Neoplasms 3Neuroectodermal Tumors, Primitive, Peripheral 3Hyperthermia 3Gliosarcoma 3Desmoplastic Small Round Cell Tumor 3Central Nervous System Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Carcinoma, Hepatocellular 3Breast Carcinoma In Situ 3Brain Neoplasms 3Uveal Melanoma 2Rhabdomyosarcoma 2Rectal Neoplasms 2

Interventions

Radiotherapy 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostate Cancer With Intermediate Risk × Brachytherapy × Clear all
NCT01039038 2011-11-28

CURIEBOOST

Centre Francois Baclesse

Phase 2 Terminated
50 enrolled
Genitourinary

Prostate Cancer With Intermediate Risk

Data powered by HemOnc (CC BY 4.0) Colophon âš¡